Results 241 to 250 of about 31,440 (256)

Rationale Use of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes

Current Diabetes Reports, 2013
Jeff Unger
exaly  

Neuroprotective effects of GLP-1 receptor agonists in neurodegenerative Disorders: A Large-Scale Propensity-Matched cohort study

International Immunopharmacology
Nabeela Siddeeque, Mohammad H Hussein, Ahmed Abdelmaksoud   +2 more
exaly  

Fair Allocation of GLP-1 and Dual GLP-1–GIP Receptor Agonists

New England Journal of Medicine
Govind, Persad, Johan L, Dellgren, Ezekiel J, Emanuel   +2 more
openaire   +6 more sources

GLP-1 receptor agonists in rheumatic disease

The Lancet Rheumatology
openaire   +2 more sources

GLP-1 receptor agonists for type 2 diabetes

The Lancet, 2009
de Block, Christophe E.M., Van Gaal, Luc F.   +1 more
openaire   +3 more sources

Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists

Journal of the American College of Cardiology
Luigi Spadafora
exaly  

GLP-1 receptor agonists in clinical practice

Medicina Clínica (English Edition)
openaire   +2 more sources

GLP-1 Receptor Agonists and NAION

Neurology
Scott N. Grossman, Valerie Biousse, Nancy J. Newman   +2 more
openaire   +1 more source

Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events

Frontiers in Pharmacology
Long He, Yongfeng Yang, Jiahao Li
exaly  

The GLP-1 Receptor Agonist Revolution

JACC
Stephen J. Nicholls, Adam J. Nelson
openaire   +1 more source